Brought to you by 
Galen buys Warner Chilcott in all stock deal
17 May 2000
Executive Summary
Galen is buying fellow UK pharma company Warner Chilcott in an all-stock transaction that values Warner at $406mm on a fully diluted basis. Warner Chilcott shareholders will get 2.5 Galen shares for each Warner American Depository Share, which trade on Nasdaq. Galen shares currently trade of the London Stock Exchange but the after the merger it will file to trade on Nasdaq also.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Galen buys Warner Chilcott in all stock deal
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice